Showing 5741-5750 of 8822 results for "".
- Stelara Adds New Approval: Crohn's Diseasehttps://practicaldermatology.com/news/stelara-adds-new-approval-crohns-disease/2458422/The FDA has approved STELARA® (ustekinumab) from Janssen Biotech, Inc., for the treatment of moderately to severely active Crohn’s disease in adults (18 years or older) who have failed or were intolerant to treatment with immunomodulators or corticost
- Regeneron and Sanofi's Dupilumab Biologics License Application Accepted for Priority Review by FDAhttps://practicaldermatology.com/news/regeneron-and-sanofis-dupilumab-biologics-license-application-accepted-for-priority-review-by-fda/2458423/The FDA has accepted for priority review the Biologics License Application (BLA) for dupilumab from Regeneron Pharmaceuticals, Inc. and Sanofi for the treatment of adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD). The application has been given a Prescription
- FDA Approves Humira Biosimilarhttps://practicaldermatology.com/news/fda-approves-humira-biosimilar/2458424/The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases. Amjevita is approved for the following indications in adult patients: ·  
- Alopecia Areata Breakthrough: Two Studies Suggest JAK inhibitors May Spur Hair Regrowthhttps://practicaldermatology.com/news/alopecia-areata-breakthrough-two-studies-suggest-jak-inhibitors-may-spur-hair-regrowth/2458427/Taken together, two new studies suggest that JAK inhibitors may play a role in treating alopecia areata. Two JAK inhibitors are already approved by the U.S. FDA, XELJANZ® (tofacitinib citrate) for rheumat
- African-American Organ Transplant Recipients at Risk for Skin Cancerhttps://practicaldermatology.com/news/african-american-organ-transplant-recipients-at-risk-for-skin-cancer/2458428/All organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer, according to researchers from Drexel University College of Medicine in Philadelphia. Out of 259 nonwhite transplant recipients who were evaluated in the study, 19 skin
- National Rosacea Society Awards Three New Grantshttps://practicaldermatology.com/news/national-rosacea-society-awards-three-new-grants/2458430/The National Rosacea Society (NRS) is funding three new studies in addition to continuing support for two ongoing studies as part of its research grants program. In this round, Luis Garza, MD, an associate professor of dermatology at Johns Hopk
- Venus Concept Unveils Venus Freeze Plus for Non-Invasive Anti-Aging Treatmentshttps://practicaldermatology.com/news/venus-concept-unveils-venus-freeze-plus-for-non-invasive-anti-aging-treatments/2458432/Venus Concept's non-invasive anti-aging device, Venus Freeze Plus, is now available in the US. It is indicated for the treatment of moderate-to-severe facial wrinkles and rhytides, leading to the tightening of the skin, with no pain or downtime. Venus Freeze Plus works by using Venus
- Save the Date: Sept 28th Marks First Ever PsA Awareness Dayhttps://practicaldermatology.com/news/save-the-date-sept-28-is-first-psa-awareness-day/2458433/September 28th marks the first-ever Psoriatic Arthritis (PsA) Awareness Day. Launched by Celgene Corporation and the National Psoriasis Foundation (NPF), PsA Awareness Day is dedicated to education, empowerment, and action for the PsA community. PsA patients can
- Allergan Bolsters Medical Derm Portfolio with Vitae Acquisitionhttps://practicaldermatology.com/news/allergan-to-acquire-vitae-pharmaceuticals/2458435/Allergan plc is acquiring Vitae Pharmaceuticals, Inc., a clinical-stage biotechnology company. The move will serve to bolster Allergan’s medical dermatology pipeline, with the addition of VTP-43742, a Phase 2 first-in-class, orally active ROR?t (retin
- ModiFace Launches AI-Based Live-Video Skin Simulation Technologyhttps://practicaldermatology.com/news/modiface-launches-ai-based-live-video-skin-simulation-technology/2458437/ModiFace, a provider of augmented reality technology for the beauty and medical industries, unveiled an artificial intelligence (AI) based video editing technology that can realistically simulate skin transformations in live video. The new Skin AI technology, which has been created with the